查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1511985

阿兹海默症诊断市场规模、份额、趋势分析报告：按诊断技术、类型、最终用途、地区和细分市场预测，2024-2030

Alzheimer's Disease Diagnostics Market Size, Share & Trends Analysis Report By Diagnostics Technique, By Type, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

阿兹海默症诊断市场的成长和趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球阿兹海默症诊断市场规模预计将达到159.2亿美元，2024年至2030年复合年增长率为11.4%。

这个市场的推动因素包括阿兹海默症（AD）盛行率的上升、生物标记在疾病诊断中的使用增加、个人化产品的日益采用以及医学影像技术的不断进步，从而导致对阿兹海默症诊断的需求预期的一些因素。政府投资和研发研究的增加进一步推动了成长。

患有阿兹海默症（最常见的失智症症）等慢性疾病的世界人口老化也是推动阿兹海默症诊断市场的主要因素。据世界卫生组织称，阿兹海默症占所有失智症的 60-70%，是最常见的失智症。根据阿兹海默症协会报告，预计到2023年，65岁以上的美国人将有670万人患有阿兹海默症。到 2060 年，这一数字预计将增加近两倍，达到 1,380 万人，而 2022 年美国阿兹海默症患者的医疗费用预计将达到约 3,210 亿美元。

新兴市场的趋势正在转向开拓更准确和非侵入性的诊断工具。最近的技术趋势导致了生物标记的发展，例如可以从脑脊髓液和血液样本中检测到的β淀粉样蛋白和Tau蛋白。这些生物标记有望早期发现阿兹海默症，从而实现早期干预和治疗。此外，功能性磁振造影（fMRI）和正子断层扫描（PET）等神经影像技术的进步正在提高阿兹海默症的诊断准确性。

阿兹海默症创新诊断技术的最新发展包括基于血液的生物标记物的开发，例如 p-tau217 测试。另一个例子是使用认知评估和穿戴式装置等数位生物标记来追踪认知能力下降并识别阿兹海默症的早期迹象。百健（Biogen）和Eisai）等公司也在投资数位健康技术，以支持临床试验并改善患者的治疗结果。此外，研究人员正在探索机器学习和自然语言处理的潜力，以分析语音模式并识别认知能力下降的早期征兆。诊断技术的这些进步预计将彻底改变阿兹海默症的诊断领域，从而实现早期疗育和更有效的治疗策略。

旨在减轻整形外科疾病负担的各种临床试验的政府资助计划的存在预计将对市场产生积极影响。这笔资金支持新诊断技术的开发，包括先进的影像技术、生物标记测定和认知评估工具。增加研发投资将有助于加快创新步伐，并将新的诊断解决方案推向市场。

市场的主要企业包括 Quest Diagnostics、Labcorp、C2N Diagnostics、 FUJIREBIO、Bristol Myers Squibb、Hoffmann-La Roche 和 Quanterix。这些公司正在采取各种策略性倡议，包括产品发布和核准，以服务其全球客户。例如，2024 年 4 月，Quest Diagnostics 宣布扩大其产品组合，增加了针对磷酸化Tau-217 (p-tau217) 的新血液生物标记测试。这些公司还提供全面的脑健康产品，在各种血液生物标记、脑脊髓液测试和基因测试方面进行创新。

阿兹海默症诊断市场报告亮点

  • 基于诊断技术，诊断影像技术在2023年占据最大的收益占有率。此类倡议预计将推动市场成长。如此高的份额是由于迫切需要早期、准确的疾病检测。电脑断层扫描 (CT)、正子断层扫描 (PET) 和功能性磁振造影 (fMRI) 等影像技术的进步已成为疾病诊断和监测的重要工具。
  • 按类型划分，诊断占据市场主导地位，并在 2023 年占据最大份额。随着社会老化，有阿兹海默症风险的人数不断增加，全球市场不断扩大。因此，对早期准确诊断工具的需求不断增加并推动市场发展。
  • 按最终用途划分，学术和研究机构将在 2023 年占据最大的市场占有率。这是由于过去十年神经系统疾病研究和临床试验的增加。学术和研究机构处于尖端研究、临床试验和创新诊断技术开发的最前沿。
  • 由于许多主要市场参与者处于阿兹海默症生物标记研究的前沿，包括脑脊髓液分析和血液生物标记物，北美在全球市场占据主导地位。这些进步正在促进更准确、侵入性更小的诊断测试的发展。
  • 预计 2024 年至 2030 年期间，亚太地区将经历最快的成长。这得归功于具有创新设备製造能力的製造商的存在以及诊断研究的加速。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章阿兹海默症诊断市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场前景
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 阿兹海默症诊断市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章阿兹海默症诊断市场：诊断技术的估计和趋势分析

  • 细分仪表板
  • 阿兹海默症诊断市场：诊断技术波动分析
  • 2018-2030年阿兹海默症诊断市场规模与趋势分析（依诊断技术）
  • 生物标誌物
  • 成像技术
  • 基因检测
  • 认知评估测试

第五章阿兹海默症诊断市场：按类型估计和趋势分析

  • 2023 年和 2030 年按类型分類的市场占有率
  • 细分仪表板
  • 全球阿兹海默症诊断市场展望：按类型
  • 2018-2030年市场规模、预测及趋势分析
  • 分类
  • 诊断
  • 筛分

第六章阿兹海默症诊断市场：依最终用途分类的估计与趋势分析

  • 2023 年及 2030 年最终用途市场占有率
  • 细分仪表板
  • 全球阿兹海默症诊断市场展望：按最终用途分类
  • 2018-2030年市场规模、预测及趋势分析
  • 医院
  • 诊断实验室
  • 学术研究所

第七章阿兹海默症诊断市场：区域估计和趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概述
  • 2018-2030年市场规模、预测趋势分析：
  • 北美洲
    • 北美：SWOT 分析
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 欧洲：SWOT 分析
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 亚太地区：SWOT 分析
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 拉丁美洲：SWOT 分析
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 中东/非洲：SWOT 分析
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 2023年主要企业市场占有率分析
    • Quest Diagnostics Incorporated
    • Laboratory Corporation of America Holdings
    • F. Hoffmann-La Roche Ltd.
    • Siemens Healthineers AG
    • C2N diagnostics
    • FujireBio
    • Bristol Myers Squibb Company
    • Quanterix
    • Sysmex
    • Lantheus
Product Code: GVR-4-68040-323-7

Alzheimer's Disease Diagnostics Market Growth & Trends:

The global Alzheimer's disease diagnostics market size is expected to reach USD 15.92 billion by 2030, registering a CAGR of 11.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by rising prevalence of Alzheimer's disease (AD), growing use of biomarkers in disease diagnostics, growing adoption of personalized products, and increasing technological advancements in medical imaging are some of the factors which is expected to drive the demand for Alzheimer's disease diagnostics. Increasing government investments and R&D studies is further propelling growth.

The global aging population with chronic conditions such as Alzheimer's disease, which is the most common form of dementia, is another major factor driving the market for Alzheimer's disease diagnostics. According to the WHO, Alzheimer's disease causes 60-70% of all instances of dementia, making it the most common kind. According to the Alzheimer's Association reports, an estimated 6.7 million Americans aged 65 and older were living with Alzheimer's disease in 2023. This number is projected to nearly triple to 13.8 million people by 2060, and the studies project that the healthcare cost for AD patients in 2022 was around USD 321 billion in the U.S, itself.

The market trends are shifting towards the development of more accurate and non-invasive diagnostic tools. Recent advances in technology have led to the development of biomarkers, such as amyloid-beta and tau proteins, which can be detected in cerebrospinal fluid or blood samples. These biomarkers have shown promise in detecting Alzheimer's disease in its early stages, allowing for earlier intervention and treatment. Additionally, advances in neuroimaging techniques, such as functional magnetic resonance imaging (fMRI) and positron emission tomography (PET), have improved the accuracy of Alzheimer's disease diagnosis.

Recent examples of innovative diagnostic technologies for Alzheimer's disease include the development of blood-based biomarkers, such as the p-tau217 test, which has shown high accuracy in detecting the disease. Another example is the use of digital biomarkers, such as cognitive assessments and wearable devices, to track cognitive decline and identify early signs of Alzheimer's disease. Companies such as Biogen and Eisai are also investing in digital health technologies to support clinical trials and improve patient outcomes. Moreover, researchers are exploring the potential of machine learning and natural language processing to analyze speech patterns and identify early signs of cognitive decline. These advances in diagnostic technology are expected to revolutionize the field of Alzheimer's disease diagnosis, enabling earlier intervention and more effective treatment strategies.

Presence of government funding programs aimed at reducing the burden of orthopedic diseases, by funding various clinical trials aimed at, is expected to have a positive impact on the market, In addition, governments are allocating substantial funds for research and development (R&D) in the field of Alzheimer's diagnostics. This funding supports the development of new diagnostic technologies, such as advanced imaging techniques, biomarker assays, and cognitive assessment tools. Increased R&D investment accelerates the pace of innovation and helps bring new diagnostic solutions to the market

Some of the key players in the market are Quest Diagnostics, Labcorp, C2N Diagnostics, Fujirebio, Bristol Myers Squibb, Hoffmann-La Roche, and Quanterix. These players are involved in various strategic initiatives such as product launch and approval in order to cater to a global clientele. For instance, in April 2024, Quest Diagnostics announced its portfolio expansion by adding a new blood biomarker test for phosphorylated tau 217 (p-tau217). Companies further have been innovating in various blood-based biomarkers, cerebrospinal fluid tests, and genetic tests to provide a comprehensive offering in brain health.

Alzheimer's Disease Diagnostics Market Report Highlights:

  • Based on diagnostics technique, imaging techniques accounted for the largest revenue share in 2023. Such initiatives are expected to drive market growth. This high share is attributable to the urgent need for early and accurate detection of the disease. Advancements in imaging technologies such as Computed Tomography (CT), Positron Emission Tomography (PET), functional MRI (fMRI) have emerged as crucial tools for diagnosing and monitoring the disease.
  • Based on type, diagnosis dominated the market and accounted for the largest share in 2023. The global market is expanding as the aging population rises, with more individuals at risk of developing Alzheimer's disease. This has heightened the demand for early and accurate diagnostic tools, driving the market forward.
  • Based on end use, academic and research institutes segment dominated the market with the largest market share in 2023. This is attributable to the increase in the research studies and clinical trials for neurological disorders over the last decade. Academic and research institutes are at the forefront of advanced research, clinical trials, and the development of innovative diagnostic techniques.
  • North America dominated the global market due to the presence of a large number of major market players at the forefront of research into Alzheimer's disease biomarkers, including cerebrospinal fluid analysis and blood-based biomarkers. These advancements are driving the development of more accurate and minimally invasive diagnostic tests.
  • Asia Pacific region is expected to witness the fastest growth over the forecast period from 2024 to 2030, due to presence of manufacturers with innovative devices manufacturing capabilities coupled with accelerated diagnostic research capabilities.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Diagnostics Technique
    • 1.2.2. Type
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Diagnostics Technique outlook
    • 2.2.2. Type outlook
    • 2.2.3. End Use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Alzheimer's Disease Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of Alzheimer's disease
      • 3.2.1.2. Increasing use of biomarkers in diagnosis
      • 3.2.1.3. Growing adoption of personalized products
      • 3.2.1.4. Growing R&D studies and government investments
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent regulations
  • 3.3. Alzheimer's Disease Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.2. PESTEL Analysis

Chapter 4. Alzheimer's Disease Diagnostics Market: Diagnostics Technique Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Alzheimer's Disease Diagnostics Market: Diagnostics Technique Movement Analysis
  • 4.3. Alzheimer's Disease Diagnostics Market Size & Trend Analysis, by diagnostic technique, 2018 to 2030 (USD Million)
  • 4.4. Biomarker
    • 4.4.1. Biomarker Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. CSF Biomarkers
      • 4.4.2.1. CSF Biomarkers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Blood Based Biomarker
      • 4.4.3.1. Blood Based Biomarker Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Imaging Techniques
    • 4.5.1. Imaging Techniques Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Genetic Testing
    • 4.6.1. Genetic Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Cognitive Assessment Tests
    • 4.7.1. Cognitive Assessment Tests Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Alzheimer's Disease Diagnostics Market: Type Estimates & Trend Analysis

  • 5.1. Type Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Alzheimer's Disease Diagnostics Market by Type Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Triage
    • 5.5.1. Triage Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Diagnosis
    • 5.6.1. Diagnosis Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Screening
    • 5.7.1. Screening Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Alzheimer's Disease Diagnostics Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Alzheimer's Disease Diagnostics Market by End Use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Hospitals
    • 6.5.1. Hospitals Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Diagnostic Laboratories
    • 6.6.1. Diagnostic Laboratories Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Academic and Research Institutes
    • 6.7.1. Academic and Research Institutes Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Alzheimer's Disease Diagnostics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. North America: SWOT Analysis
    • 7.5.2. U.S.
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/Reimbursement
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/Reimbursement
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/Reimbursement
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. Europe: SWOT Analysis
    • 7.6.2. UK
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/Reimbursement
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. Germany
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/Reimbursement
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. France
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/Reimbursement
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Italy
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/Reimbursement
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Spain
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/Reimbursement
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Norway
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework/Reimbursement
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Sweden
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/Reimbursement
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.9. Denmark
      • 7.6.9.1. Key country dynamics
      • 7.6.9.2. Regulatory framework/Reimbursement
      • 7.6.9.3. Competitive scenario
      • 7.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Asia Pacific: SWOT Analysis
    • 7.7.2. Japan
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/Reimbursement
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. China
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/Reimbursement
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. India
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/Reimbursement
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. Australia
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/Reimbursement
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. South Korea
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework/Reimbursement
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.7. Thailand
      • 7.7.7.1. Key country dynamics
      • 7.7.7.2. Regulatory framework/Reimbursement
      • 7.7.7.3. Competitive scenario
      • 7.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Latin America: SWOT Analysis
    • 7.8.2. Brazil
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/Reimbursement
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework/Reimbursement
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. MEA: SWOT Analysis
    • 7.9.2. South Africa
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/Reimbursement
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. Saudi Arabia
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/Reimbursement
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. UAE
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework/Reimbursement
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.5. Kuwait
      • 7.9.5.1. Key country dynamics
      • 7.9.5.2. Regulatory framework
      • 7.9.5.3. Competitive scenario
      • 7.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. Quest Diagnostics Incorporated
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Services benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Laboratory Corporation of America Holdings
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Services benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. F. Hoffmann-La Roche Ltd.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Services benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Siemens Healthineers AG
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Services benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. C2N diagnostics
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Services benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. FujireBio
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Services benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Bristol Myers Squibb Company
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Services benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Quanterix
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Services benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Sysmex
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Services benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Lantheus
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Services benchmarking
      • 8.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America Alzheimer's disease diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America Alzheimer's disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
  • Table 4 North America Alzheimer's disease diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 5 North America Alzheimer's disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 U.S. Alzheimer's disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
  • Table 7 U.S. Alzheimer's disease diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 8 U.S. Alzheimer's disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Canada Alzheimer's disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
  • Table 10 Canada Alzheimer's disease diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 11 Canada Alzheimer's disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Mexico Alzheimer's disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
  • Table 13 Mexico Alzheimer's disease diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 14 Mexico Alzheimer's disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe Alzheimer's disease diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 16 Europe Alzheimer's disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
  • Table 17 Europe Alzheimer's disease diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 18 Europe Alzheimer's disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Germany Alzheimer's disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
  • Table 20 Germany Alzheimer's disease diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 21 Germany Alzheimer's disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 UK Alzheimer's disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
  • Table 23 UK Alzheimer's disease diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 24 UK Alzheimer's disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 France Alzheimer's disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
  • Table 26 France Alzheimer's disease diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 27 France Alzheimer's disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Italy Alzheimer's disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
  • Table 29 Italy Alzheimer's disease diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 30 Italy Alzheimer's disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Spain Alzheimer's disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
  • Table 32 Spain Alzheimer's disease diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 33 Spain Alzheimer's disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Denmark Alzheimer's disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
  • Table 35 Denmark Alzheimer's disease diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 36 Denmark Alzheimer's disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Sweden Alzheimer's disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
  • Table 38 Sweden Alzheimer's disease diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 39 Sweden Alzheimer's disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Norway Alzheimer's disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
  • Table 41 Norway Alzheimer's disease diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 42 Norway Alzheimer's disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Alzheimer's disease diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Alzheimer's disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Alzheimer's disease diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Alzheimer's disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 China Alzheimer's disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
  • Table 48 China Alzheimer's disease diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 49 China Alzheimer's disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Japan Alzheimer's disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
  • Table 51 Japan Alzheimer's disease diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 52 Japan Alzheimer's disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 India Alzheimer's disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
  • Table 54 India Alzheimer's disease diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 55 India Alzheimer's disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 South Korea Alzheimer's disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
  • Table 57 South Korea Alzheimer's disease diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 58 South Korea Alzheimer's disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Australia Alzheimer's disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
  • Table 60 Australia Alzheimer's disease diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 61 Australia Alzheimer's disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Thailand Alzheimer's disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
  • Table 63 Thailand Alzheimer's disease diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 64 Thailand Alzheimer's disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 Latin America Alzheimer's disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
  • Table 66 Latin America Alzheimer's disease diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 67 Latin America Alzheimer's disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 68 Brazil Alzheimer's disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
  • Table 69 Brazil Alzheimer's disease diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 70 Brazil Alzheimer's disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 71 Argentina Alzheimer's disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
  • Table 72 Argentina Alzheimer's disease diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 73 Argentina Alzheimer's disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 74 MEA Alzheimer's disease diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 75 MEA Alzheimer's disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
  • Table 76 MEA Alzheimer's disease diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 77 MEA Alzheimer's disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 78 South Africa Alzheimer's disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
  • Table 79 South Africa Alzheimer's disease diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 80 South Africa Alzheimer's disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia Alzheimer's disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Alzheimer's disease diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Alzheimer's disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 84 UAE Alzheimer's disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
  • Table 85 UAE Alzheimer's disease diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 86 UAE Alzheimer's disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 87 Kuwait Alzheimer's disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Alzheimer's disease diagnostics market, by type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Alzheimer's disease diagnostics market: market outlook
  • Fig. 14 Alzheimer's disease diagnostics competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Alzheimer's disease diagnostics market driver impact
  • Fig. 20 Alzheimer's disease diagnostics market restraint impact
  • Fig. 21 Alzheimer's disease diagnostics market strategic initiatives analysis
  • Fig. 22 Alzheimer's disease diagnostics market: Diagnostics technique movement analysis
  • Fig. 23 Alzheimer's disease diagnostics market: Diagnostics technique outlook and key takeaways
  • Fig. 24 Biomarkers market estimates and forecast, 2018 - 2030
  • Fig. 25 CSF biomarkers estimates and forecast, 2018 - 2030
  • Fig. 26 Blood based biomarkers market estimates and forecast, 2018 - 2030
  • Fig. 27 Imaging techniques estimates and forecast, 2018 - 2030
  • Fig. 28 Genetic testing market estimates and forecast, 2018 - 2030
  • Fig. 29 Cognitive assessment tests market estimates and forecasts,2018 - 2030
  • Fig. 30 Alzheimer's disease diagnostics Market: Test type movement analysis
  • Fig. 31 Alzheimer's disease diagnostics market: Test type outlook and key takeaways
  • Fig. 32 Triage market estimates and forecasts, 2018 - 2030
  • Fig. 33 Diagnosis market estimates and forecasts,2018 - 2030
  • Fig. 34 Screening market estimates and forecasts,2018 - 2030
  • Fig. 35 Alzheimer's disease diagnostics market: End-use movement analysis
  • Fig. 36 Alzheimer's disease diagnostics market: End-use outlook and key takeaways
  • Fig. 37 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 38 Diagnostic laboratories market estimates and forecasts,2018 - 2030
  • Fig. 39 Academic and research institutes market estimates and forecasts, 2018 - 2030
  • Fig. 40 Global Alzheimer's disease diagnostics market: Regional movement analysis
  • Fig. 41 Global Alzheimer's disease diagnostics market: Regional outlook and key takeaways
  • Fig. 42 Global Alzheimer's disease diagnostics market share and leading players
  • Fig. 43 North America market share and leading players
  • Fig. 44 Europe market share and leading players
  • Fig. 45 Asia Pacific market share and leading players
  • Fig. 46 Latin America market share and leading players
  • Fig. 47 Middle East & Africa market share and leading players
  • Fig. 48 North America: SWOT
  • Fig. 49 Europe SWOT
  • Fig. 50 Asia Pacific SWOT
  • Fig. 51 Latin America SWOT
  • Fig. 52 MEA SWOT
  • Fig. 53 North America, by country
  • Fig. 54 North America
  • Fig. 55 North America market estimates and forecasts, 2018 - 2030
  • Fig. 56 U.S.
  • Fig. 57 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 58 Canada
  • Fig. 59 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 60 Mexico
  • Fig. 61 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 62 Europe
  • Fig. 63 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 64 UK
  • Fig. 65 UK market estimates and forecasts, 2018 - 2030
  • Fig. 66 Germany
  • Fig. 67 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 68 France
  • Fig. 69 France market estimates and forecasts, 2018 - 2030
  • Fig. 70 Italy
  • Fig. 71 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 72 Spain
  • Fig. 73 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 74 Denmark
  • Fig. 75 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 76 Sweden
  • Fig. 77 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 78 Norway
  • Fig. 79 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 80 Asia Pacific
  • Fig. 81 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 82 China
  • Fig. 83 China market estimates and forecasts, 2018 - 2030
  • Fig. 84 Japan
  • Fig. 85 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 86 India
  • Fig. 87 India market estimates and forecasts, 2018 - 2030
  • Fig. 88 Thailand
  • Fig. 89 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 90 South Korea
  • Fig. 91 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 92 Australia
  • Fig. 93 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 94 Latin America
  • Fig. 95 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 96 Brazil
  • Fig. 97 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 98 Argentina
  • Fig. 99 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 100 Middle East and Africa
  • Fig. 101 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 102 South Africa
  • Fig. 103 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 104 Saudi Arabia
  • Fig. 105 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 106 UAE
  • Fig. 107 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 108 Kuwait
  • Fig. 109 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 110 Market share of key market players- Alzheimer's disease diagnostics market